Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • JDisc Discovery Reviews & Ratings
    30 Ratings
    Company Website
  • AthenaHQ Reviews & Ratings
    50 Ratings
    Company Website
  • Criminal IP ASM Reviews & Ratings
    21 Ratings
    Company Website
  • Superfiliate Reviews & Ratings
    49 Ratings
    Company Website
  • Digital WarRoom Reviews & Ratings
    55 Ratings
    Company Website
  • FrameworkLTC Reviews & Ratings
    48 Ratings
    Company Website
  • Cloverleaf Reviews & Ratings
    189 Ratings
    Company Website
  • RallyFuel Reviews & Ratings
    1 Rating
    Company Website
  • Eurekos Reviews & Ratings
    103 Ratings
    Company Website
  • 11x Reviews & Ratings
    70 Ratings
    Company Website

What is Atomwise?

Our cutting-edge AI platform is transforming the drug discovery landscape, allowing us to create high-quality medications more rapidly than ever before. Backed by a wide array of discovery assets, both independently owned and co-developed with partners, and supported by prestigious investors, we are making considerable advancements in the sector. Atomwise has developed a machine-learning discovery engine that harnesses the power of convolutional neural networks in conjunction with vast chemical libraries to pinpoint new small-molecule drugs. The true potential of AI in revolutionizing drug discovery is rooted in the dedication and expertise of our team. We are committed to developing state-of-the-art AI tools that enhance the discovery of small molecules, targeting some of the most challenging and seemingly impossible objectives while optimizing the overall drug development process. By increasing computational efficiency, we can digitally screen trillions of compounds, significantly improving the likelihood of successful outcomes. Our models have achieved exceptional accuracy, effectively reducing the occurrence of false positives and setting the stage for groundbreaking medical innovations. As we continue to refine our technology, our ultimate goal is to equip researchers with the necessary tools to inspire innovation and deliver impactful results in the realm of drug discovery. This commitment to advancing the field is at the core of our mission.

What is AarogyaAI?

AarogyaAI is an innovative software-as-a-service (SaaS) platform enhanced by artificial intelligence that can detect drug-resistant tuberculosis in just a few hours. Our goal is to streamline the diagnosis process for drug-resistant tuberculosis (DR-TB) utilizing cutting-edge AI technology, facilitating rapid and accurate treatment suggestions. Tuberculosis remains one of the top causes of death, outpacing even AIDS, largely because of the unpredictability regarding which of the 19 available anti-TB medications will work for individual patients. This uncertainty can result in extended periods—sometimes lasting as long as seven years—during which patients endure ineffective treatments, even though the disease is treatable. By delivering results within hours, AarogyaAI guarantees that patients receive the most appropriate drug combinations for their specific needs without unnecessary wait times. The methodology involves submitting a patient's DNA sequence to our platform, where our sophisticated machine learning algorithms conduct an analysis and produce a comprehensive report on drug susceptibility. This streamlined approach not only conserves time but also enhances health outcomes for individuals battling drug-resistant tuberculosis. With its transformative approach, AarogyaAI is redefining how TB diagnostics and treatments are administered, demonstrating a significant leap forward in the fight against this global health challenge. In essence, our platform exemplifies the intersection of technology and healthcare, paving the way for more effective solutions in managing complex diseases.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Web-Based Support

Training Options

Documentation Hub
Webinars
On-Site Training

Training Options

Not specified

Company Facts

Organization Name

Atomwise

Date Founded

2012

Company Location

United States

Company Website

www.atomwise.com

Company Facts

Organization Name

AarogyaAI

Company Location

India

Company Website

aarogya.ai/

Categories and Features

Drug Discovery

Not specified

Healthcare AI

Not specified

Categories and Features

Healthcare AI

Not specified

Popular Alternatives

StarDrop Reviews & Ratings

StarDrop

Optibrium

Popular Alternatives

Augmento Reviews & Ratings

Augmento

DeepTek
Prescription Pad Reviews & Ratings

Prescription Pad

CompuRx Infotech
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA
emocha Reviews & Ratings

emocha

emocha Health